These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25751132)

  • 1. Impact of cardiovascular treatments and systolic dysfunction on nutritional risk in patients with ischemic and valvular heart disease.
    Boban M; Persic V; Petricevic M; Manola S; Boban L; Vcev A
    J Am Coll Nutr; 2015; 34(2):159-66. PubMed ID: 25751132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.
    Boban M; Zulj M; Persic V; Medved I; Zekanovic D; Vcev A
    Int J Cardiol; 2016 Sep; 219():277-81. PubMed ID: 27343420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of NRS-2002 Nutritional Risk Screening in patients hospitalized for secondary cardiovascular prevention and rehabilitation.
    Boban M; Laviano A; Persic V; Rotim A; Jovanovic Z; Vcev A
    J Am Coll Nutr; 2014; 33(6):466-73. PubMed ID: 25387165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connections between nutritional status and proton pump inhibitor therapy in patients scheduled for cardiovascular rehabilitation after treatment for ischaemic and valvular heart disease.
    Boban M; Persic V; Petricevic M; Biocina B; Sipic T; Pehar-Pejcnovic V; Balen S; Zulj M; Vcev A
    Kardiol Pol; 2016; 74(5):461-468. PubMed ID: 26412474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and seasonal variations of nutritional risk screening in patients scheduled for rehabilitation after heart surgery.
    Boban M; Persic V; Jovanovic Z; Drinkovic N; Milosevic M; Laviano A
    Heart Surg Forum; 2013 Dec; 16(6):E336-43. PubMed ID: 24370803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity dilemma in the global burden of cardiovascular diseases.
    Boban M; Persic V; Jovanovic Z; Brozina A; Miletic B; Rotim A; Drinkovic N; Manola S; Laskarin G; Boban L
    Int J Clin Pract; 2014 Feb; 68(2):173-9. PubMed ID: 24355081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart surgery stems increased nutritional risk, expressed during the course of stationary rehabilitation.
    Boban M; Persic V; Miletic B; Kovacicek K; Madzar Z
    Ann Nutr Metab; 2013; 63(1-2):17-24. PubMed ID: 23867581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Transiently Increased Nutritional Risk on a Left Ventricle Myocardial Mass Assessed by Echocardiography.
    Boban M; Laviano A; Persic V; Biocina B; Petricevic M; Zekanovic D; Rotim C; Aleric I; Vcev A
    Ann Nutr Metab; 2016; 68(3):197-202. PubMed ID: 27022986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
    Tarantini L; Faggiano P; Senni M; Lucci D; Bertoli D; Porcu M; Opasich C; Tavazzi L; Maggioni AP
    Ital Heart J; 2002 Nov; 3(11):656-64. PubMed ID: 12506524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction.
    Gandhi PS; Goyal RK; Jain AR; Mallya BS; Gupta VM; Shah DS; Trivedi BR; Shastri NA; Mehta CB; Jain KA; Bhavasar NS; Shah UJ
    Can J Physiol Pharmacol; 2007 Feb; 85(2):193-9. PubMed ID: 17487260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medical therapy on left ventricular ejection fraction in patients with systolic heart failure and narrow QRS duration with and without ischemic heart disease and left ventricular mechanical dyssynchrony.
    Nair CK; Shen X; Aronow WS; Li H; Holmberg MJ; Korlakunta H; Hee T; Maciejewski S; Esterbrooks DJ
    Am J Ther; 2010; 17(1):e1-7. PubMed ID: 19262361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function.
    Chukwuemeka A; Rao V; Armstrong S; Ivanov J; David T
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):133-8. PubMed ID: 16386914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.